Evolution of the Average Target: Exponent, Inc.

Evolution of the Target Price: Exponent, Inc.

Changes in Analyst Recommendations: Exponent, Inc.

29eca02b722ac2b11fafa651780.-vNJmdWJfzn0m6ARBpTztmXwswHGTMHGq43NPkIYvo8.n6YMrJ3lD0OS3ZBgMqfHzyOC9ku8e_Gw2sS3Ext54buruyHA7dMsT8Si9Q~cf4a9f433205bb1697555a7214e76834
05-01 UBS Adjusts Price Target on Exponent to $75 From $85, Maintains Neutral Rating MT
02-09 UBS Lifts Price Target on Exponent to $85 From $81, Maintains Neutral Rating MT
01-26 JPMorgan Initiates Coverage on Exponent With Overweight Rating, $100 Price Target MT
11-17 William Blair Upgrades Exponent to Outperform From Market Perform MT
01/08/25 UBS Adjusts Price Target on Exponent to $76 From $84, Maintains Neutral Rating MT
25/10/24 UBS Adjusts Price Target on Exponent to $112 From $110, Maintains Neutral Rating MT
26/07/24 UBS Adjusts Exponent Price Target to $110 From $88, Maintains Neutral Rating MT
26/07/24 Truist Adjusts Price Target on Exponent to $120 From $100, Maintains Buy Rating MT
26/04/24 Truist Securities Adjusts Exponent's Price Target to $100 From $95, Keeps Buy Rating MT
31/07/23 Truist Securities Adjusts Exponent's Price Target to $110 From $120, Keeps Buy Rating MT
01/06/23 UBS Initiates Coverage on Exponent With Neutral Rating, $99 Price Target MT
01/07/22 Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors MT
06/05/22 Berenberg Bank Adjusts Exponent's' Price Target to $116 From $135, Maintains Buy Rating MT
05/04/22 Truist Securities Adjusts Exponent's Price Target to $120 From $115, Reiterates Buy Rating MT
01/11/21 Truist Securities Adjusts Exponent's Price Target to $126 From $118, Reiterates Buy Rating MT
08/10/21 EXPONENT : Berenberg Bank Boosts Price Target on Exponent to $135 From $112, Maintains Buy Rating MT
02/08/21 EXPONENT : Truist Securities Adjusts Exponent's Price Target to $118 From $110, Reiterates Buy Rating MT
24/03/21 EXPONENT : Berenberg Bank Adjusts Exponent PT to $112 From $95, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+44.24%
+16.79%
+20.36%
+25.3%
+25.67%
+5.3%
+7.51%
+11.34%
+33.13%
+18.67%
Average +20.83%
Weighted average by Cap. +18.33%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
56.62USD
Average target price
81.67USD
Spread / Average Target
+44.24%
High Price Target
90.00USD
Spread / Highest target
+58.95%
Low Price Target
75.00USD
Spread / Lowest Target
+32.46%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
JPMorgan Chase
William Blair & Co.
Truist Securities
Berenberg Bank
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
56.62USD
Average target price
81.67USD
Spread / Average Target
+44.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EXPO Stock
  4. Consensus Exponent, Inc.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!